Brief: GlycoMimetics posts Q2 basic EPS USD -0.13
02/08/2023 12:32
Aug 2 (Reuters) - GlycoMimetics Q2 basic EPS USD -0.13. * Q2 income from operations USD -8.93 million * Q2 net income USD -8.259 million
Recent news on Crescent Biopharma
See all newsBrief: Crescent Biopharma - Potential To Initiate First CR-001 Phase 3 Study In Early 2028
Brief: Crescent Biopharma Announces FDA Clearance Of Ind Application For CR-002, A Pd-L1-Targeted Topoisomerase Inhibitor Adc, For The Treatment Of Solid Tumors
Crescent Biopharma posts smaller-than-expected Q2 net loss
U.S. STOCKS ON THE MOVE-Cintas, Veradermics
Crescent Biopharma slips on $125 mln share offering